Pinned Tweet
🚨🔖Don't miss our new publication in @LIjournal!
🔷Comprehensive Spatial Transcriptomic Profiling of Cribriform, Intraductal, Atypical Intraductal Proliferation, and Ductal Adenocarcinoma of the Prostate
➡️Read here: laboratoryinvestigation.org/article/S0023-…
@MGBpathology @IntSocUropath th #MolPath #SpatialTranscriptomics #ProstateCancer
🔷Comprehensive Spatial Transcriptomic Profiling of Cribriform, Intraductal, Atypical Intraductal Proliferation, and Ductal Adenocarcinoma of the Prostate
➡️Read here: laboratoryinvestigation.org/article/S0023-…
@MGBpathology @IntSocUropath th #MolPath #SpatialTranscriptomics #ProstateCancer
New from Laboratory Investigation 🔬 | Using spatial transcriptomics to characterize cribriform, intraductal, atypical intraductal proliferation, and ductal adenocarcinoma of the prostate. @TingZhaoPathdoc
🔗 Zhao et al. Read the article: buff.ly/0P8n93u
9
12
49
6,303
@MGBpathology Check out the multi-institutional study led by Drs. Jennifer Nguyen @patholojenMD and Ankur Sangoi @slusagar!
▶️ link.springer.com/article/10.100…
#GUpath #MolPath
▶️ link.springer.com/article/10.100…
#GUpath #MolPath
0
0
1
13
@MGBpathologyVacuolated Tumor (EVT) #GUpath #MolPath
🔷Soli#MolPath with eosinophilic cytoplasm containing intracytoplasmic vacuoles, and prominent nucleoli
🔷IHC: PAX8+, CD117+, CD10+, cathepsin K+ (~75–80%), GPNMB+, CD56+ (~98%); CK7 and CK20- or rare/focal (PMID: 34521993, 39033022, 4298, TSC2, or MTOR alterations with mTORC1 activation; mostly somatic, rarely associated with germline TSC1/TSC2 alterations (tuberous sclerosis complex), as in this case
🔷Prognosis: Generally indolent; lymph node metastasis rarely reported (PMID: 40474716, 41171101)
🔷Soli#MolPath with eosinophilic cytoplasm containing intracytoplasmic vacuoles, and prominent nucleoli
🔷IHC: PAX8+, CD117+, CD10+, cathepsin K+ (~75–80%), GPNMB+, CD56+ (~98%); CK7 and CK20- or rare/focal (PMID: 34521993, 39033022, 4298, TSC2, or MTOR alterations with mTORC1 activation; mostly somatic, rarely associated with germline TSC1/TSC2 alterations (tuberous sclerosis complex), as in this case
🔷Prognosis: Generally indolent; lymph node metastasis rarely reported (PMID: 40474716, 41171101)
0
0
3
21
Ting Zhao, MD retweeted
Heading to #AMP2026 and wondering what to do before the meeting starts?
Join us at Special Programs Day for @cytopathology session, Nov 10 at 5 pm
Included with your meeting registration but you have to sign up
Maximizing #CytoPath for #MolPath 🧬
#supernatants #NGS @AMPath
Join us at Special Programs Day for @cytopathology session, Nov 10 at 5 pm
Included with your meeting registration but you have to sign up
Maximizing #CytoPath for #MolPath 🧬
#supernatants #NGS @AMPath
1
10
24
896
Ting Zhao, MD retweeted
Applications are now open for the MGB Womens and Perinatal Pathology Fellowship starting July 2028. Find out more here: research.massgeneralbrigham.org/en/education-a… #gynpath #PathTwitter #pathology #pathologyfellowship
1
2
10
1,042
Ting Zhao, MD retweeted
Join us for our next Distinguished Lecture Series session featuring Dr. Jesse K. McKenney
Topic: Spindle Cell Lesions of the Genitourinary Tract
Moderators:Dr. Emily Chan @chemily7, Dr. Rohit Mehra @drmehrarohit
Nov 5, 12 PM Eastern time
Register here: us02web.zoom.us/webinar/regist…
0
10
25
1,320
Excited to share that I have 2 first-author abstracts and several co-authored abstracts accepted for #USCAP2027!
@MGBpathology @TheUSCAP
#GUPath #MolPath
@MGBpathology @TheUSCAP
#GUPath #MolPath
6
2
71
2,497
@MGBpathologyibriform Hyperplasia #GUpath
💠 Cons#GUpatha form of benign prostatic hyperplasia
💠 Typically involves the transition zone
💠 Benign, cribriform architecture
💠 Intact basal layer; bland nuclei; pale cytoplasm
💠 Mimics IDC-P, AIP and invasive cribriform carcinoma
💠 Cons#GUpatha form of benign prostatic hyperplasia
💠 Typically involves the transition zone
💠 Benign, cribriform architecture
💠 Intact basal layer; bland nuclei; pale cytoplasm
💠 Mimics IDC-P, AIP and invasive cribriform carcinoma
1
2
10
533
🔖 Considering where to submit your urological research?
♦️Therapeutic Advances in Urology (IF 3.5) @TA_Urology welcomes original research, reviews, meta-analyses, clinical guidelines, and more across urological research.
As an Editorial Board member, I encourage you to r work!
💠 Explore published articles:
journals.sagepub.com/home/TAU
#UrologicalResearch #GU
♦️Therapeutic Advances in Urology (IF 3.5) @TA_Urology welcomes original research, reviews, meta-analyses, clinical guidelines, and more across urological research.
As an Editorial Board member, I encourage you to r work!
💠 Explore published articles:
journals.sagepub.com/home/TAU
#UrologicalResearch #GU
1
2
8
988
Ting Zhao, MD retweeted
🎤 Calling all AMP trainees with talent! Perform in the #AMP2026 talent show and receive a complimentary ticket to the Amazing Molecular Party on Nov. 13!
Email meetings@amp.org by Oct. 30 with your proposed act (five minutes maximum).
Email meetings@amp.org by Oct. 30 with your proposed act (five minutes maximum).
1
1
0
339
Heading to #AMP2026? Don’t miss the plenary presentations and awards ceremony!
@AMPath #MolPath #PrecisionMedicine
@AMPath #MolPath #PrecisionMedicine
0
9
17
1,376
Ting Zhao, MD retweeted
Today marks the beginning of a new era in cancer care.
Alongside leaders from across the Commonwealth, the @CityOfBoston, @BIDMChealth, and the broader community, we broke ground on the Lavine Bekenstein Hospital at Dana-Farber. This 450,000-square-foot facility will include ss 10 floors and has been designed specifically around the needs of people with cancer and their families. Built to support the next generation of cancer treatment, the hospital will bring together world-class clinical care, groundbreaking research, and advanced technology on a single, integrated campus.
This hospital was made possible through a joint philanthropic commitment from Josh and Anita Bekenstein and the Jonathan and Jeannie Lavine family. This transformational gift—the largest single gift in our history—builds on both families’ decades-long dedication to our mission: delivering expert, compassionate patient care while accelerating discoveries that improve outcomes for people with cancer around the world.
Located along Brookline Avenue, the hospital will become the centerpiece of a closely coordinated campus linking Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, and @HMFPBoston. The facility has been designed to accommodate rapid advances in oncology, providing flexible clinical space capable of adapting to future innovations in cancer treatment and research.
Learn more about this historic ceremony: bit.ly/4zEk3YZ
Alongside leaders from across the Commonwealth, the @CityOfBoston, @BIDMChealth, and the broader community, we broke ground on the Lavine Bekenstein Hospital at Dana-Farber. This 450,000-square-foot facility will include ss 10 floors and has been designed specifically around the needs of people with cancer and their families. Built to support the next generation of cancer treatment, the hospital will bring together world-class clinical care, groundbreaking research, and advanced technology on a single, integrated campus.
This hospital was made possible through a joint philanthropic commitment from Josh and Anita Bekenstein and the Jonathan and Jeannie Lavine family. This transformational gift—the largest single gift in our history—builds on both families’ decades-long dedication to our mission: delivering expert, compassionate patient care while accelerating discoveries that improve outcomes for people with cancer around the world.
Located along Brookline Avenue, the hospital will become the centerpiece of a closely coordinated campus linking Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, and @HMFPBoston. The facility has been designed to accommodate rapid advances in oncology, providing flexible clinical space capable of adapting to future innovations in cancer treatment and research.
Learn more about this historic ceremony: bit.ly/4zEk3YZ
2
17
76
11,856
Ting Zhao, MD retweeted
Dana-Farber breaks ground on cancer hospital boston25news.com/news/local/dan…
0
10
36
2,809
Ting Zhao, MD retweeted
Applications are OPEN for the Medical Student Genomics Workshop at #USCAP2027! Explore genomic testing through hands-on, case-based learning with expert faculty. Travel awards up to $1,000 are available. Apply by December 2!
buff.ly/8ChCbtu
buff.ly/8ChCbtu
0
5
7
879
Ting Zhao, MD retweeted
Special thanks to our moderators- Dr. Cornelia Ding @ckcding and Dr. Aiman Haider @aimhaider for the #IAP2026 #GUPS event
0
5
13
891